J.M. de Laat
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients (NCT05037461) | J.M. de Laat | 2022-05-01 |
Track J.M. de Laat automatically
Every clearance here is in the API, with alerts when new ones post.